{"log_id": 4395917725659420134, "direction": 0, "words_result_num": 40, "words_result": [{"probability": {"variance": 0, "average": 0.999961, "min": 0.999961}, "location": {"width": 56, "top": 102, "height": 36, "left": 1125}, "words": "药"}, {"probability": {"variance": 0.015801, "average": 0.932258, "min": 0.538878}, "location": {"width": 852, "top": 138, "height": 124, "left": 150}, "words": "配对比较P值:依那西普+甲氨蝶呤VS甲氨蝶呤tp<0.05;依那西普+甲氨蝶呤VS依那西普"}, {"probability": {"variance": 0.017626, "average": 0.935287, "min": 0.50375}, "location": {"width": 230, "top": 176, "height": 55, "left": 147}, "words": "c:将DAS<1.6视为缓解"}, {"probability": {"variance": 3e-05, "average": 0.994986, "min": 0.9847}, "location": {"width": 40, "top": 264, "height": 20, "left": 194}, "words": "<0.05"}, {"probability": {"variance": 1.8e-05, "average": 0.997897, "min": 0.979493}, "location": {"width": 811, "top": 276, "height": 110, "left": 205}, "words": "12个月时,依那西普单药治疗比MTX单药治疗的放射相进展较小。与依那西普组"}, {"probability": {"variance": 0.002358, "average": 0.98713, "min": 0.702709}, "location": {"width": 844, "top": 332, "height": 107, "left": 164}, "words": "或MTX单独用药相比,依那西普M1X联用后放射相进展得到显著改善(参见下图)"}, {"probability": {"variance": 0.001886, "average": 0.98894, "min": 0.736365}, "location": {"width": 808, "top": 537, "height": 91, "left": 222}, "words": "放射相进展:比较依那西普、甲氨蝶呤以及依那西普/甲氨蝶呤合用治疗病程为6"}, {"probability": {"variance": 0.006438, "average": 0.979341, "min": 0.61207}, "location": {"width": 452, "top": 602, "height": 65, "left": 377}, "words": "个月-20年的RA患者(治疗12个月的结果)"}, {"probability": {"variance": 0.000747, "average": 0.964172, "min": 0.926473}, "location": {"width": 42, "top": 708, "height": 24, "left": 467}, "words": "280"}, {"probability": {"variance": 0, "average": 0.991497, "min": 0.991497}, "location": {"width": 82, "top": 699, "height": 22, "left": 824}, "words": " Methotre"}, {"probability": {"variance": 0.020749, "average": 0.89555, "min": 0.691859}, "location": {"width": 33, "top": 714, "height": 22, "left": 305}, "words": "3.0"}, {"probability": {"variance": 0, "average": 0.779082, "min": 0.779082}, "location": {"width": 58, "top": 724, "height": 21, "left": 828}, "words": " Enbrel"}, {"probability": {"variance": 0.000373, "average": 0.954133, "min": 0.943874}, "location": {"width": 150, "top": 744, "height": 27, "left": 826}, "words": " Enbrel+Mefhot"}, {"probability": {"variance": 0.04674, "average": 0.846167, "min": 0.540421}, "location": {"width": 35, "top": 775, "height": 21, "left": 308}, "words": "2.5"}, {"probability": {"variance": 0.006099, "average": 0.926382, "min": 0.817009}, "location": {"width": 35, "top": 838, "height": 22, "left": 310}, "words": "2.0"}, {"probability": {"variance": 4e-06, "average": 0.995667, "min": 0.992538}, "location": {"width": 42, "top": 836, "height": 21, "left": 650}, "words": "1.68"}, {"probability": {"variance": 0.012059, "average": 0.920959, "min": 0.733208}, "location": {"width": 99, "top": 897, "height": 24, "left": 247}, "words": "81.5"}, {"probability": {"variance": 0.000107, "average": 0.987845, "min": 0.97325}, "location": {"width": 40, "top": 898, "height": 20, "left": 831}, "words": "112"}, {"probability": {"variance": 0, "average": 0.768357, "min": 0.768357}, "location": {"width": 18, "top": 956, "height": 18, "left": 252}, "words": "E"}, {"probability": {"variance": 0.001258, "average": 0.972347, "min": 0.922271}, "location": {"width": 32, "top": 962, "height": 22, "left": 316}, "words": "1.0"}, {"probability": {"variance": 0.001141, "average": 0.973785, "min": 0.926041}, "location": {"width": 30, "top": 1025, "height": 21, "left": 319}, "words": "0.5"}, {"probability": {"variance": 0.002961, "average": 0.96668, "min": 0.872442}, "location": {"width": 40, "top": 1018, "height": 22, "left": 700}, "words": "0.21"}, {"probability": {"variance": 0.003163, "average": 0.948975, "min": 0.870021}, "location": {"width": 34, "top": 1087, "height": 24, "left": 319}, "words": "0.0"}, {"probability": {"variance": 0.002927, "average": 0.932672, "min": 0.853316}, "location": {"width": 63, "top": 1099, "height": 25, "left": 921}, "words": "0.23中"}, {"probability": {"variance": 0.001778, "average": 0.964214, "min": 0.888879}, "location": {"width": 45, "top": 1122, "height": 22, "left": 742}, "words": "0.301"}, {"probability": {"variance": 4.4e-05, "average": 0.991125, "min": 0.983633}, "location": {"width": 35, "top": 1148, "height": 20, "left": 319}, "words": "0.5"}, {"probability": {"variance": 0.032577, "average": 0.896582, "min": 0.536206}, "location": {"width": 51, "top": 1158, "height": 22, "left": 566}, "words": "0.541"}, {"probability": {"variance": 0.086577, "average": 0.790309, "min": 0.374191}, "location": {"width": 154, "top": 1140, "height": 57, "left": 817}, "words": "医药"}, {"probability": {"variance": 0.000517, "average": 0.978317, "min": 0.944839}, "location": {"width": 37, "top": 1208, "height": 20, "left": 320}, "words": "-1.0"}, {"probability": {"variance": 0.03605, "average": 0.739221, "min": 0.530946}, "location": {"width": 303, "top": 1207, "height": 36, "left": 479}, "words": "Tss— Erosions"}, {"probability": {"variance": 0.05589, "average": 0.787769, "min": 0.430797}, "location": {"width": 119, "top": 1194, "height": 32, "left": 873}, "words": "JSN1"}, {"probability": {"variance": 0.010745, "average": 0.95209, "min": 0.523198}, "location": {"width": 814, "top": 1237, "height": 64, "left": 250}, "words": "配对比较p值:依那西普vs甲氨蝶呤*=p≤0.05;依那西普+甲氨蝶呤vs甲氨蝶呤"}, {"probability": {"variance": 0.03425, "average": 0.871814, "min": 0.411183}, "location": {"width": 572, "top": 1270, "height": 64, "left": 251}, "words": "p<0.05;依那西普+甲氨蝶呤vS依那西普中P<0.05。1"}, {"probability": {"variance": 5.7e-05, "average": 0.996816, "min": 0.964156}, "location": {"width": 825, "top": 1362, "height": 64, "left": 242}, "words": "治疗24个月后,与依那西普组或MTX单独用药相比,依那西普MTX联用后放射"}, {"probability": {"variance": 0.000213, "average": 0.994547, "min": 0.935134}, "location": {"width": 710, "top": 1420, "height": 54, "left": 199}, "words": "性进展也得到显著改善。同样依那西普单药治疗也优于MTX单药治疗"}, {"probability": {"variance": 1e-06, "average": 0.999198, "min": 0.995849}, "location": {"width": 824, "top": 1465, "height": 56, "left": 245}, "words": "在一项分析中,将试验中由于任何原因脱落的患者均视为发生进展,治疗24个月"}, {"probability": {"variance": 1.7e-05, "average": 0.997084, "min": 0.983295}, "location": {"width": 873, "top": 1515, "height": 56, "left": 199}, "words": "时与单独使用依那西普或甲氨蝶呤相比,依那西普与甲氨蝶呤合并使用后未出现进展"}, {"probability": {"variance": 0.00181, "average": 0.980264, "min": 0.846766}, "location": {"width": 858, "top": 1570, "height": 44, "left": 209}, "words": "TSS改变≤0.5)的患者比例较高(分别为50%,36%和62%;p<0.05)。依那西普和甲"}, {"probability": {"variance": 0.000485, "average": 0.986047, "min": 0.921518}, "location": {"width": 162, "top": 1664, "height": 24, "left": 192}, "words": "版本号:20090118"}, {"probability": {"variance": 5e-06, "average": 0.99831, "min": 0.993096}, "location": {"width": 178, "top": 1654, "height": 29, "left": 802}, "words": "第18页共31页"}], "language": 3}